Mikael Oerum

Mikael Oerum has extensive experience in various leadership roles within the biotech and pharmaceutical industries. Mikael has served as the Chairman of the Board of Directors for multiple companies, including QMed Consulting A/S, Cenexum Technologies, Orbit Genomics, Inc., RhoVac AB, and Amunix Pharmaceuticals, Inc. Oerum has also been a Board Member for IXALTIS SA and an Advisory Board Member for Cube Labs, where they have contributed to the development and growth of these organizations. Additionally, they are the founder and partner of Ventac Partners, an international company specializing in identifying innovative discoveries and advancements in pharma and diagnostics. Oerum has successfully led strategic initiatives and turnarounds for companies such as Neuroscience Technologies S.L.P. and Neuroscience Technologies Ltd. and Avexxin AS (now Coegin Pharma AB). Mikael'sexpertise lies in building organizations, securing funding, and driving business growth in the healthcare technology sector.

Mikael Oerum has an education in banking, finance, and law, as well as an officers education. No specific details about the start or end year, degree name, or field of study are provided.